Natural Allergy Relief - Source Naturals AllerStrength
If you're longing for some serious Seasonal Allergy relief, look no further. Source Naturals AllerStrength will provide you with safe & effective Allergy relief. Source Naturals AllerStrength will help to stop the release of Histamine in your body, & is easy for on-the-go relief. It will also provide support for your overall Eye health during Seasonal discomfort. Get relief from even the worst Allergies now. Pick up a bottle today. Introducing Source Naturals AllerStrength!!
Source Naturals AllerStrength Benefits
- Helps To Halt Histamine Release
- Provides Support To Overall Eye Health During Seasonal Discomfort
- 100% Vegan & Vegetarian Friendly
- Completely Dairy & Yeast Free
- Relieves Harsh Symptoms Of Allergies
- Provides Natural & Effective Allergy Relief
- Absolutely No Preservatives Added
- Easy Supplement To Take On-The-Go
How Do I Take Source Naturals AllerStrength?
Source Naturals recommends taking one (1) tablet twice daily, or as directed by your Health Care Professional.
Source Naturals AllerStrength Ingredients
Serving Size: 1 Tablet
Servings Per Container: 60
Vitamin C (As Magnesium Ascorbate) 50mg
Magnesium (As Magnesium Ascorbate) 3mg
EMIQ Complex 167mg (Providing 50mg Enzymatically Modified Isoquercetin)
Other Ingredients: Dibasic Calcium Phosphate, Microcrystalline Cellulose, Hydroxypropylcellulose, And Magnesium Stearate.
Source Naturals AllerStrength Side Effects & Warnings
If you are pregnant, may become pregnant, or breastfeeding, consult your Health Care Professional before using this product.
Amado NG, Predes D, Fonseca BF, et al. Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt/β-catenin signaling pathway. J Biol Chem. 2014;289(51):35456‐35467. doi:10.1074/jbc.M114.621599
Tan S, Caparros-Martin JA, Matthews VB, et al. Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet. Sci Rep. 2018;8(1):10100. Published 2018 Jul 4. doi:10.1038/s41598-018-28521-8